Brief progress report from the intersocietal working group on differentiated thyroid cancer

Frederik A Verburg¹, Sukhjeet Ahuja², Anca M Avram³, Manuel Bardiès⁴, Victor Bernet⁵, Patrick Bourguet⁶, Dagmar Führer-Sakel⁷, Ciprian Draganescu⁶, Gilbert H Daniels^{8

9}, Bennett Greenspan², Seza Gulec¹⁰, Laszlo Hegedüs¹¹, Jacqueline Jonklaas¹², Markus Luster¹³, Wim Oyen^{14

15

16

17

18}, Johannes Smit¹⁹, R Michael Tuttle²⁰, Slimane Zerdoud²¹, Douglas Van Nostrand²²

Affiliations

¹ Department of Nuclear Medicine, University Hospital Marburg, Baldinger Straße, 35043, Marburg, Germany. verburg@med.uni-marburg.de.
² Society of Nuclear Medicine, Reston, USA.
³ University of Michigan Medical Center, Ann Arbor, MI, USA.
⁴ Centre de Recherches en Cancérologie de Toulouse and UMR 1037, INSERM, Université Toulouse III Paul Sabatier, Toulouse, France.
⁵ Mayo Clinic College of Medicine, Rochester, FL, USA.
⁶ University Hospital of Martinique, University of Antilles, Pointe-à-Pitre, France.
⁷ Department of Endocrinology, University Hospital Essen, Essen, Germany.
⁸ Thyroid Unit and Cancer Center Massachusetts General Hospital, Boston, MA, USA.
⁹ Harvard Medical School, Boston, MA, USA.
¹⁰ Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
¹¹ Department of Endocrinology, Odense University Hospital, Odense, Denmark.
¹² Division of Endocrinology, Georgetown University, Washington, DC, USA.
¹³ Department of Nuclear Medicine, University Hospital Marburg, Baldinger Straße, 35043, Marburg, Germany.
¹⁴ European Association of Nuclear Medicine, Vienna, Austria.
¹⁵ Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
¹⁶ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
¹⁷ Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy.
¹⁸ Department of Radiology and Nuclear Medicine, Radboud UMC, Nijmegen, The Netherlands.
¹⁹ Department of Internal Medicine, Radboud UMC, Nijmegen, The Netherlands.
²⁰ Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²¹ Department of Nuclear Medicine, University Cancer Center Toulouse Oncopole, Toulouse, France.
²² Washington Hospital Center, Washington, DC, USA.

PMID: 32166513
PMCID: PMC7188695
DOI: 10.1007/s00259-020-04744-8

Editorial

Brief progress report from the intersocietal working group on differentiated thyroid cancer

Frederik A Verburg et al. Eur J Nucl Med Mol Imaging. 2020 Jun.

. 2020 Jun;47(6):1345-1347.

doi: 10.1007/s00259-020-04744-8.

Authors

Affiliations

¹ Department of Nuclear Medicine, University Hospital Marburg, Baldinger Straße, 35043, Marburg, Germany. verburg@med.uni-marburg.de.
² Society of Nuclear Medicine, Reston, USA.
³ University of Michigan Medical Center, Ann Arbor, MI, USA.
⁴ Centre de Recherches en Cancérologie de Toulouse and UMR 1037, INSERM, Université Toulouse III Paul Sabatier, Toulouse, France.
⁵ Mayo Clinic College of Medicine, Rochester, FL, USA.
⁶ University Hospital of Martinique, University of Antilles, Pointe-à-Pitre, France.
⁷ Department of Endocrinology, University Hospital Essen, Essen, Germany.
⁸ Thyroid Unit and Cancer Center Massachusetts General Hospital, Boston, MA, USA.
⁹ Harvard Medical School, Boston, MA, USA.
¹⁰ Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
¹¹ Department of Endocrinology, Odense University Hospital, Odense, Denmark.
¹² Division of Endocrinology, Georgetown University, Washington, DC, USA.
¹³ Department of Nuclear Medicine, University Hospital Marburg, Baldinger Straße, 35043, Marburg, Germany.
¹⁴ European Association of Nuclear Medicine, Vienna, Austria.
¹⁵ Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
¹⁶ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
¹⁷ Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy.
¹⁸ Department of Radiology and Nuclear Medicine, Radboud UMC, Nijmegen, The Netherlands.
¹⁹ Department of Internal Medicine, Radboud UMC, Nijmegen, The Netherlands.
²⁰ Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²¹ Department of Nuclear Medicine, University Cancer Center Toulouse Oncopole, Toulouse, France.
²² Washington Hospital Center, Washington, DC, USA.

PMID: 32166513
PMCID: PMC7188695
DOI: 10.1007/s00259-020-04744-8

No abstract available

PubMed Disclaimer

Conflict of interest statement

FAV has received consultancy fees from SanofiGenzyme, Jubilant Draximage and EISAI, speaker honoraria from SanofiGenzyme as well as research support from EISAI.

MB has been a consultant to BTG, Bayer, Roche, IPSEN and MEDPACE.

ML was a consultant for AstraZeneca, Bayer Healthcare, SanofiGenzyme, EASAI, Jubilant Draximage and Sobi and has received speaker honoraria and research support from SanofiGenzyme, Henning and Merck.

DvN is a consultant to Jubilant Draximage.

The other authors have no relevant conflicts of interest to declare.

References

1. Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, et al. Controversies, consensus and collaboration in the use of I-131 therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Society of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29:461–470. doi: 10.1089/thy.2018.0597. - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Brief progress report from the intersocietal working group on differentiated thyroid cancer

Affiliations

Brief progress report from the intersocietal working group on differentiated thyroid cancer

Authors

Affiliations

Conflict of interest statement

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical